Browse By: Country ι Category ι Latest Reports ι Tag
Home  »  Global Markets Direct

Global Markets Direct Market Research Reports

Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials.

At the heart of Global Markets Direct are unique databases, updated live, covering millions of rows of key information for the studied industry at a global level.

Allergic Rhinitis - Pipeline Review, H1 2015
Global Markets Directs, Allergic Rhinitis Pipeline Review, H1 2015, provides an overview of the Allergic Rhinitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Allergic Rhinitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Metastatic Pancreatic Cancer - Pipeline Review, H1 2015
Global Markets Directs, Metastatic Pancreatic Cancer Pipeline Review, H1 2015, provides an overview of the Metastatic Pancreatic Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Pancreatic Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Pancreatic Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2015
Global Markets Directs, Wet (Neovascular / Exudative) Macular Degeneration Pipeline Review, H1 2015, provides an overview of the Wet (Neovascular / Exudative) Macular Degenerations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Wet (Neovascular / Exudative) Macular Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Wet (Neovascular / Exudative) Macular Degeneration and special features on late-stage and discontinued projects. Global Markets Directs report fea
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Brain Cancer - Pipeline Review, H1 2015
Global Markets Directs, Brain Cancer Pipeline Review, H1 2015, provides an overview of the Brain Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Brain Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and informatio
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Dementia - Pipeline Review, H1 2015
Global Markets Directs, Dementia Pipeline Review, H1 2015, provides an overview of the Dementias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dementia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dementia and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from G
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015
Global Markets Directs, Non-Alcoholic Steatohepatitis Pipeline Review, H1 2015, provides an overview of the Non-Alcoholic Steatohepatitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Non-Alcoholic Steatohepatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Non-Alcoholic Steatohepatitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nea
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Diarrhea - Pipeline Review, H1 2015
Global Markets Directs, Diarrhea Pipeline Review, H1 2015, provides an overview of the Diarrheas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diarrhea and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from G
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Candidiasis - Pipeline Review, H1 2015
Global Markets Directs, Candidiasis Pipeline Review, H1 2015, provides an overview of the Candidiasiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Candidiasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Candidiasis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information so
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015
Global Markets Directs, Metastatic Renal Cell Carcinoma Pipeline Review, H1 2015, provides an overview of the Metastatic Renal Cell Carcinomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Renal Cell Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Renal Cell Carcinoma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas a
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Diabetic Macular Edema - Pipeline Review, H1 2015
Global Markets Directs, Diabetic Macular Edema Pipeline Review, H1 2015, provides an overview of the Diabetic Macular Edemas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic Macular Edema, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Macular Edema and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The r
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Hodgkin Lymphoma - Pipeline Review, H1 2015
Global Markets Directs, Hodgkin Lymphoma Pipeline Review, H1 2015, provides an overview of the Hodgkin Lymphomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hodgkin Lymphoma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Endometriosis - Pipeline Review, H1 2015
Global Markets Directs, Endometriosis Pipeline Review, H1 2015, provides an overview of the Endometriosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Endometriosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Endometriosis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and inform
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Autism - Pipeline Review, H1 2015
Global Markets Directs, Autism Pipeline Review, H1 2015, provides an overview of the Autisms therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Autism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Autism and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Ma
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2015
Global Markets Directs, Coronary Artery Disease (CAD) (Ischemic Heart Disease) Pipeline Review, H1 2015, provides an overview of the Coronary Artery Disease (CAD) (Ischemic Heart Disease)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease) and special features on late-stage and discontinued projects. Global Markets Di
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Pertussis - Pipeline Review, H1 2015
Global Markets Directs, Pertussis Pipeline Review, H1 2015, provides an overview of the Pertussiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pertussis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pertussis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced fr
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015
Global Markets Directs, Chemotherapy Induced Neutropenia Pipeline Review, H1 2015, provides an overview of the Chemotherapy Induced Neutropenias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Neutropenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Neutropenia and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy a
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2015
Global Markets Directs, Acute Renal Failure (ARF) (Acute Kidney Injury) Pipeline Review, H1 2015, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury) and special features on late-stage and discontinued projects. Global Markets Directs report features invest
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015
Global Markets Directs, Spinal Muscular Atrophy (SMA) Pipeline Review, H1 2015, provides an overview of the Spinal Muscular Atrophy (SMA)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Spinal Muscular Atrophy (SMA), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Spinal Muscular Atrophy (SMA) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nea
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2015
Global Markets Directs, Post-Traumatic Stress Disorder (PTSD) Pipeline Review, H1 2015, provides an overview of the Post-Traumatic Stress Disorder (PTSD)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Post-Traumatic Stress Disorder (PTSD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Post-Traumatic Stress Disorder (PTSD) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe coveri
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Atrial Fibrillation - Pipeline Review, H1 2015
Global Markets Directs, Atrial Fibrillation Pipeline Review, H1 2015, provides an overview of the Atrial Fibrillations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Atrial Fibrillation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Atrial Fibrillation and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is bui
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Amyloidosis - Pipeline Review, H1 2015
Global Markets Directs, Amyloidosis Pipeline Review, H1 2015, provides an overview of the Amyloidosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Amyloidosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Amyloidosis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information so
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015
Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) Pipeline Review, H1 2015’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cognitive Impairment Associated With Schizophrenia (CIAS), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cognitive Impairment Associated With Schizophrenia (CIAS) and special features on late-stage and dis
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Growth Hormone Deficiency - Pipeline Review, H1 2015
Global Markets Directs, Growth Hormone Deficiency Pipeline Review, H1 2015, provides an overview of the Growth Hormone Deficiencys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Growth Hormone Deficiency, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Growth Hormone Deficiency and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indica
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Diabetic Neuropathic Pain - Pipeline Review, H1 2015
Global Markets Directs, Diabetic Neuropathic Pain Pipeline Review, H1 2015, provides an overview of the Diabetic Neuropathic Pains therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic Neuropathic Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Neuropathic Pain and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indica
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
High Triglyceridemia - Pipeline Review, H1 2015
Global Markets Directs, High Triglyceridemia Pipeline Review, H1 2015, provides an overview of the High Triglyceridemias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for High Triglyceridemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for High Triglyceridemia and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Erectile Dysfunction - Pipeline Review, H1 2015
Global Markets Directs, Erectile Dysfunction Pipeline Review, H1 2015, provides an overview of the Erectile Dysfunctions therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Erectile Dysfunction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Erectile Dysfunction and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Chronic Plaque Psoriasis - Pipeline Review, H1 2015
Global Markets Directs, Chronic Plaque Psoriasis Pipeline Review, H1 2015, provides an overview of the Chronic Plaque Psoriasiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Plaque Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Plaque Psoriasis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indication
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Nasopharyngeal Cancer - Pipeline Review, H1 2015
Global Markets Directs, Nasopharyngeal Cancer Pipeline Review, H1 2015, provides an overview of the Nasopharyngeal Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Nasopharyngeal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Nasopharyngeal Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The repor
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Constipation - Pipeline Review, H1 2015
Global Markets Directs, Constipation Pipeline Review, H1 2015, provides an overview of the Constipations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Constipation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Constipation and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and informatio
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Metastatic Prostate Cancer - Pipeline Review, H1 2015
Metastatic Prostate Cancer - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Metastatic Prostate Cancer - Pipeline Review, H1 2015, provides an overview of the Metastatic Prostate Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Metastatic Prostate Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Prostate Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2015
ine Review, H1 2015SummaryGlobal Markets Directs, Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2015, provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Non Alcoholic Fatty Liver Disease (NAFLD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Non Alcoholic Fatty Liver Disease (NAFLD) and special features on late-stage and discontinued projects.Global Markets Directs report features investigationa
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Insulin Resistance - Pipeline Review, H1 2015
Insulin Resistance - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Insulin Resistance - Pipeline Review, H1 2015, provides an overview of the Insulin Resistances therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Insulin Resistance, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Insulin Resistance and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearl
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015
Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015, provides an overview of the Onychomycosis (Tinea Unguium)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Onychomycosis (Tinea Unguium), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Onychomycosis (Tinea Unguium) and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs fro
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015
Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015, provides an overview of the Peripheral Neuropathy (Sensory Neuropathy)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy) and special features on late-stage and discontinued projects
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2015
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2015, provides an overview of the Ventilator Associated Pneumonia (VAP)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Ventilator Associated Pneumonia (VAP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ventilator Associated Pneumonia (VAP) and special features on late-stage and discontinued projects.Global Markets Directs r
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Malignant Glioma - Pipeline Review, H1 2015
Malignant Glioma - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Malignant Glioma - Pipeline Review, H1 2015, provides an overview of the Malignant Gliomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Malignant Glioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Malignant Glioma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 in
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Thromboembolism - Pipeline Review, H1 2015
Thromboembolism - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Thromboembolism - Pipeline Review, H1 2015, provides an overview of the Thromboembolisms therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Thromboembolism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thromboembolism and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Warts - Pipeline Review, H1 2015
e Review, H1 2015SummaryGlobal Markets Directs, Warts - Pipeline Review, H1 2015, provides an overview of the Wartss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Warts, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Warts and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015, provides an overview of the Secondary Progressive Multiple Sclerosis (SPMS)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Secondary Progressive Multiple Sclerosis (SPMS), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Secondary Progressive Multiple Sclerosis (SPMS) and special features on late-stage
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Myasthenia Gravis - Pipeline Review, H1 2015
Myasthenia Gravis - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Myasthenia Gravis - Pipeline Review, H1 2015, provides an overview of the Myasthenia Graviss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Myasthenia Gravis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myasthenia Gravis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Sarcopenia - Pipeline Review, H1 2015
Sarcopenia - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Sarcopenia - Pipeline Review, H1 2015, provides an overview of the Sarcopenias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Sarcopenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sarcopenia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Obsessive-Compulsive Disorder - Pipeline Review, H1 2015
Obsessive-Compulsive Disorder - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Obsessive-Compulsive Disorder - Pipeline Review, H1 2015, provides an overview of the Obsessive-Compulsive Disorders therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Obsessive-Compulsive Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Obsessive-Compulsive Disorder and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs fro
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Helicobacter Pylori Infections - Pipeline Review, H1 2015
w, H1 2015SummaryGlobal Markets Directs, Helicobacter Pylori Infections - Pipeline Review, H1 2015, provides an overview of the Helicobacter Pylori Infectionss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Helicobacter Pylori Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Helicobacter Pylori Infections and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy ar
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Myotonic Dystrophy - Pipeline Review, H1 2015
Myotonic Dystrophy - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Myotonic Dystrophy - Pipeline Review, H1 2015, provides an overview of the Myotonic Dystrophys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Myotonic Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myotonic Dystrophy and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearl
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Acute Heart Failure - Pipeline Review, H1 2015
Acute Heart Failure - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Acute Heart Failure - Pipeline Review, H1 2015, provides an overview of the Acute Heart Failures therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Heart Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Heart Failure and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Otitis Media - Pipeline Review, H1 2015
15SummaryGlobal Markets Directs, Otitis Media - Pipeline Review, H1 2015, provides an overview of the Otitis Medias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Otitis Media, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Otitis Media and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2015
Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2015, provides an overview of the Elephantiasis (Lymphatic Filariasis)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Elephantiasis (Lymphatic Filariasis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Elephantiasis (Lymphatic Filariasis) and special features on late-stage and discontinued projects.Global Markets Directs report
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Recurrent Malignant Glioma - Pipeline Review, H1 2015
Recurrent Malignant Glioma - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Recurrent Malignant Glioma - Pipeline Review, H1 2015, provides an overview of the Recurrent Malignant Gliomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Recurrent Malignant Glioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Recurrent Malignant Glioma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Trauma - Pipeline Review, H1 2015
Trauma - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Trauma - Pipeline Review, H1 2015, provides an overview of the Traumas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Trauma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Trauma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and info
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Biliary Cirrhosis - Pipeline Review, H1 2015
Biliary Cirrhosis - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Biliary Cirrhosis - Pipeline Review, H1 2015, provides an overview of the Biliary Cirrhosiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Biliary Cirrhosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Biliary Cirrhosis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,0
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Influenza B Infections - Pipeline Review, H1 2015
Influenza B Infections - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Influenza B Infections - Pipeline Review, H1 2015, provides an overview of the Influenza B Infectionss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Influenza B Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Influenza B Infections and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Perennial Allergic Rhinitis - Pipeline Review, H1 2015
Perennial Allergic Rhinitis - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Perennial Allergic Rhinitis - Pipeline Review, H1 2015, provides an overview of the Perennial Allergic Rhinitiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Perennial Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Perennial Allergic Rhinitis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across g
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Nerve Injury - Pipeline Review, H1 2015
Nerve Injury - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Nerve Injury - Pipeline Review, H1 2015, provides an overview of the Nerve Injurys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Nerve Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Nerve Injury and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The repor
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Nasopharyngitis (Common Cold) - Pipeline Review, H1 2015
Nasopharyngitis (Common Cold) - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Nasopharyngitis (Common Cold) - Pipeline Review, H1 2015, provides an overview of the Nasopharyngitis (Common Cold)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Nasopharyngitis (Common Cold), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Nasopharyngitis (Common Cold) and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs fro
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Botulism - Pipeline Review, H1 2015
Botulism - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Botulism - Pipeline Review, H1 2015, provides an overview of the Botulisms therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Botulism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Botulism and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Seasonal Allergic Rhinitis - Pipeline Review, H1 2015
Seasonal Allergic Rhinitis - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Seasonal Allergic Rhinitis - Pipeline Review, H1 2015, provides an overview of the Seasonal Allergic Rhinitiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Seasonal Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Seasonal Allergic Rhinitis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Brain Injury - Pipeline Review, H1 2015
Brain Injury - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Brain Injury - Pipeline Review, H1 2015, provides an overview of the Brain Injurys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Brain Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Injury and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The repor
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Birch Pollen Allergy - Pipeline Review, H1 2015
Birch Pollen Allergy - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Birch Pollen Allergy - Pipeline Review, H1 2015, provides an overview of the Birch Pollen Allergys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Birch Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Birch Pollen Allergy and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Typhoid Fever - Pipeline Review, H1 2015
Typhoid Fever - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Typhoid Fever - Pipeline Review, H1 2015, provides an overview of the Typhoid Fevers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Typhoid Fever, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Typhoid Fever and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Anaplastic Thyroid Cancer - Pipeline Review, H1 2015
Anaplastic Thyroid Cancer - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Anaplastic Thyroid Cancer - Pipeline Review, H1 2015, provides an overview of the Anaplastic Thyroid Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Anaplastic Thyroid Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anaplastic Thyroid Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe cover
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Polycystic Ovarian Syndrome - Pipeline Review, H1 2015
Polycystic Ovarian Syndrome - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Polycystic Ovarian Syndrome - Pipeline Review, H1 2015, provides an overview of the Polycystic Ovarian Syndromes therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Polycystic Ovarian Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Polycystic Ovarian Syndrome and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across g
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Status Epilepticus - Pipeline Review, H1 2015
Status Epilepticus - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Status Epilepticus - Pipeline Review, H1 2015, provides an overview of the Status Epilepticuss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Status Epilepticus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Status Epilepticus and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearl
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Acute Sensorineural Hearing Loss - Pipeline Review, H1 2015
Acute Sensorineural Hearing Loss - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Acute Sensorineural Hearing Loss - Pipeline Review, H1 2015, provides an overview of the Acute Sensorineural Hearing Losss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Sensorineural Hearing Loss, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Sensorineural Hearing Loss and special features on late-stage and discontinued projects.Global Markets Directs report features investigat
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Thrombocythaemia Myelofibrosis - Pipeline Review, H1 2015
Thrombocythaemia Myelofibrosis - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Thrombocythaemia Myelofibrosis - Pipeline Review, H1 2015, provides an overview of the Thrombocythaemia Myelofibrosiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Thrombocythaemia Myelofibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thrombocythaemia Myelofibrosis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drug
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Community Acquired Pneumonia - Pipeline Review, H1 2015
Community Acquired Pneumonia - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Community Acquired Pneumonia - Pipeline Review, H1 2015, provides an overview of the Community Acquired Pneumonias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Community Acquired Pneumonia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Community Acquired Pneumonia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from acr
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2015
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2015, provides an overview of the Juvenile Macular Degeneration (Stargardt Disease)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Juvenile Macular Degeneration (Stargardt Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Juvenile Macular Degeneration (Stargardt Disease) and special features on l
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2015
Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2015, provides an overview of the Microscopic Polyangiitis (MPA)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Microscopic Polyangiitis (MPA), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Microscopic Polyangiitis (MPA) and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drug
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Sedation - Pipeline Review, H1 2015
Sedation - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Sedation - Pipeline Review, H1 2015, provides an overview of the Sedations therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Sedation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sedation and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Prader-Willi Syndrome (PWS) - Pipeline Review, H1 2015
ome (PWS) - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Prader-Willi Syndrome (PWS) - Pipeline Review, H1 2015, provides an overview of the Prader-Willi Syndrome (PWS)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Prader-Willi Syndrome (PWS), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Prader-Willi Syndrome (PWS) and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Bacterial Vaginosis - Pipeline Review, H1 2015
Bacterial Vaginosis - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Bacterial Vaginosis - Pipeline Review, H1 2015, provides an overview of the Bacterial Vaginosiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Bacterial Vaginosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bacterial Vaginosis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015, provides an overview of the Diabetic Peripheral Neuropathys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Diabetic Peripheral Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Peripheral Neuropathy and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drug
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Leiomyosarcoma - Pipeline Review, H1 2015
Leiomyosarcoma - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Leiomyosarcoma - Pipeline Review, H1 2015, provides an overview of the Leiomyosarcomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Leiomyosarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Leiomyosarcoma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2015
Pipeline Review, H1 2015SummaryGlobal Markets Directs, Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2015, provides an overview of the Female Hypoactive Sexual Desire Disorders therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Female Hypoactive Sexual Desire Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Female Hypoactive Sexual Desire Disorder and special features on late-stage and discontinued projects.Global Markets Directs report features investigation
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Fatigue - Pipeline Review, H1 2015
Fatigue - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Fatigue - Pipeline Review, H1 2015, provides an overview of the Fatigues therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Fatigue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Fatigue and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Primary Sclerosing Cholangitis - Pipeline Review, H1 2015
Primary Sclerosing Cholangitis - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Primary Sclerosing Cholangitis - Pipeline Review, H1 2015, provides an overview of the Primary Sclerosing Cholangitiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Primary Sclerosing Cholangitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Primary Sclerosing Cholangitis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drug
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Charcot-Marie-Tooth Disease - Pipeline Review, H1 2015
Charcot-Marie-Tooth Disease - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Charcot-Marie-Tooth Disease - Pipeline Review, H1 2015, provides an overview of the Charcot-Marie-Tooth Diseases therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Charcot-Marie-Tooth Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Charcot-Marie-Tooth Disease and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across g
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Pyelonephritis - Pipeline Review, H1 2015
Pyelonephritis - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Pyelonephritis - Pipeline Review, H1 2015, provides an overview of the Pyelonephritiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Pyelonephritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pyelonephritis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H1 2015
015SummaryGlobal Markets Directs, Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H1 2015, provides an overview of the Proliferative Vitreoretinopathy (PVR)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Proliferative Vitreoretinopathy (PVR), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Proliferative Vitreoretinopathy (PVR) and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe coveri
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Premenstrual Syndrome - Pipeline Review, H1 2015
Premenstrual Syndrome - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Premenstrual Syndrome - Pipeline Review, H1 2015, provides an overview of the Premenstrual Syndromes therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Premenstrual Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Premenstrual Syndrome and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Tardive Dyskinesia - Pipeline Review, H1 2015
Tardive Dyskinesia - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Tardive Dyskinesia - Pipeline Review, H1 2015, provides an overview of the Tardive Dyskinesias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Tardive Dyskinesia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Tardive Dyskinesia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearl
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H1 2015
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H1 2015, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Iron Deficiency Anemia - Pipeline Review, H1 2015
Iron Deficiency Anemia - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Iron Deficiency Anemia - Pipeline Review, H1 2015, provides an overview of the Iron Deficiency Anemias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Iron Deficiency Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Iron Deficiency Anemia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Chlamydia Trachomatis Infections - Pipeline Review, H1 2015
Chlamydia Trachomatis Infections - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Chlamydia Trachomatis Infections - Pipeline Review, H1 2015, provides an overview of the Chlamydia Trachomatis Infectionss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chlamydia Trachomatis Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chlamydia Trachomatis Infections and special features on late-stage and discontinued projects.Global Markets Directs report features investigat
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Kaposi's Sarcoma - Pipeline Review, H1 2015
Kaposi's Sarcoma - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Kaposi's Sarcoma - Pipeline Review, H1 2015, provides an overview of the Kaposi's Sarcomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Kaposi's Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Kaposi's Sarcoma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 in
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Phenylketonuria (PKU) - Pipeline Review, H1 2015
Phenylketonuria (PKU) - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Phenylketonuria (PKU) - Pipeline Review, H1 2015, provides an overview of the Phenylketonuria (PKU)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Phenylketonuria (PKU), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Phenylketonuria (PKU) and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Follicular Thyroid Cancer - Pipeline Review, H1 2015
Follicular Thyroid Cancer - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Follicular Thyroid Cancer - Pipeline Review, H1 2015, provides an overview of the Follicular Thyroid Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Follicular Thyroid Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Follicular Thyroid Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe cover
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Paraganglioma (Glomus Jugulare Tumor) - Pipeline Review, H1 2015
Paraganglioma (Glomus Jugulare Tumor) - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Paraganglioma (Glomus Jugulare Tumor) - Pipeline Review, H1 2015, provides an overview of the Paraganglioma (Glomus Jugulare Tumor)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Paraganglioma (Glomus Jugulare Tumor), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Paraganglioma (Glomus Jugulare Tumor) and special features on late-stage and discontinued projects.Global Markets Directs r
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Blepharitis - Pipeline Review, H1 2015
Blepharitis - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Blepharitis - Pipeline Review, H1 2015, provides an overview of the Blepharitiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Blepharitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Blepharitis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Post-Operative Pain - Pipeline Review, H1 2015
Post-Operative Pain - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Post-Operative Pain - Pipeline Review, H1 2015, provides an overview of the Post-Operative Pains therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Post-Operative Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Post-Operative Pain and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Primary Biliary Cirrhosis - Pipeline Review, H1 2015
Review, H1 2015SummaryGlobal Markets Directs, Primary Biliary Cirrhosis - Pipeline Review, H1 2015, provides an overview of the Primary Biliary Cirrhosiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Primary Biliary Cirrhosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Primary Biliary Cirrhosis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Oral Mucositis - Pipeline Review, H1 2015
Oral Mucositis - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Oral Mucositis - Pipeline Review, H1 2015, provides an overview of the Oral Mucositiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Oral Mucositis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Oral Mucositis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Peritoneal Cancer - Pipeline Review, H1 2015
Global Markets Directs, Peritoneal Cancer - Pipeline Review, H1 2015, provides an overview of the Peritoneal Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Peritoneal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peritoneal Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built usi
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Breast Cancer - Pipeline Review, H1 2015
Global Markets Directs, Breast Cancer Pipeline Review, H1 2015, provides an overview of the Breast Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Breast Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Breast Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and inform
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2500
Asthma - Pipeline Review, H1 2015
Global Markets Directs, Asthma Pipeline Review, H1 2015, provides an overview of the Asthmas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Asthma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Asthma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Ma
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2500
Ulcerative Colitis - Pipeline Review, H1 2015
Global Markets Directs, Ulcerative Colitis Pipeline Review, H1 2015, provides an overview of the Ulcerative Colitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ulcerative Colitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ulcerative Colitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built u
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Glaucoma - Pipeline Review, H1 2015
Global Markets Directs, Glaucoma Pipeline Review, H1 2015, provides an overview of the Glaucomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Glaucoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Glaucoma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from G
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Pulmonary Fibrosis - Pipeline Review, H1 2015
Global Markets Directs, Pulmonary Fibrosis Pipeline Review, H1 2015, provides an overview of the Pulmonary Fibrosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pulmonary Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pulmonary Fibrosis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built u
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Dengue - Pipeline Review, H1 2015
Global Markets Directs, Dengue Pipeline Review, H1 2015, provides an overview of the Dengues therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dengue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dengue and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Ma
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Dyslipidemia - Pipeline Review, H1 2015
Global Markets Directs, Dyslipidemia Pipeline Review, H1 2015, provides an overview of the Dyslipidemias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dyslipidemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dyslipidemia and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and informatio
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Pneumocystis Infection - Pipeline Review, H2 2014
Pneumocystis Infection - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Pneumocystis Infection - Pipeline Review, H2 2014, provides an overview of the Pneumocystis Infections therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Pneumocystis Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pneumocystis Infection and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Dec 2014
Published By: Global Markets Direct

Price: $2000